CPH
Creso Pharma
- Short interest
- 0.06%
- −0.01 pp 30d
- as of 8 June 2023
- Reported shorts
- 1.6M
- Shares on issue
- 2.567B
Creso Pharma (CPH) company profile
Profile, insiders and operations
Company
AI-generated research profile of Creso Pharma
Pharmaceuticals
Biotechnology
Healthcare
ASX
Therapeutics
Creso Pharma is an ASX-listed pharmaceutical company focused on the development and commercialization of innovative therapeutic products. The company aims to address unmet medical needs through its research and development pipeline, potentially leveraging novel drug delivery systems or active pharmaceutical ingredients. Its market position is likely within niche therapeutic areas, striving for differentiation through scientific innovation and clinical efficacy.
Director trades
No director trades found
CPH intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required